Skip to main content
SpringerLink
Log in

The clinical relevance of drug–drug interaction between co-trimoxazole and sacubitril/valsartan treatment in a heart failure patient: a case report and overview of mechanisms and management in clinical practice

  • Letter to the Editors
  • Published:
Clinical Research in Cardiology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. McMurray JJ, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, Rouleau JL, Shi VC, Solomon SD, Swedberg K, Zile MR, PARADIGM-HF Investigators and Committees (2014) Angiotensin-neprilysin inhibition versus enalapril in heart failure. N Engl J Med 371:993–1004

    Article  PubMed  CAS  Google Scholar 

  2. McMurray JJ (2016) The use of sacubitril/valsartan (LCZ696) in clinical practice. Br J Cardiol 23(suppl 1):S1-S16

    Google Scholar 

  3. U.S. Food and Drug Administration. ENTRESTO (sacubitril and valsartan). Highlights of prescribing information. http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/207620Orig1s000lbl.pdf. Accessed 11 June 2017

  4. Ponikowski P, Voors AA, Anker SD, Task Force Members et al (2016) ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 37:2129–2200

    Article  PubMed  Google Scholar 

  5. Palmer BF (2004) Managing hyperkalemia caused by inhibitors of the renin–angiotensin–aldosterone system. N Engl J Med 351:585–592

    Article  PubMed  CAS  Google Scholar 

  6. Ben Salem C, Badreddine A, Fathallah N, Slim R, Hmouda H (2014) Drug-induced hyperkalemia. Drug Saf 37:677–692

    Article  PubMed  CAS  Google Scholar 

  7. Bistola V, Simitsis P, Farmakis D, Ikonomidis I, Bakosis G, Triposkiadis F, Hatziagelaki E, Lekakis J, Mebazaa A, Parissis J (2017) Association of mineralocorticoid receptor antagonist use and in-hospital outcomes in patients with acute heart failure. Clin Res Cardiol https://doi.org/10.1007/s00392-017-1161-7 (pMID: 28921054, [Epub ahead of print])

    Article  PubMed  Google Scholar 

  8. Fu M, Ahrenmark U, Berglund S, Lindholm CJ, Lehto A, Broberg AM, Tasevska-Dinevska G, Wikstrom G, Ågard A, Andersson B, All investigators of the HR-HF study (2017) Adherence to optimal heart rate control in heart failure with reduced ejection fraction: insight from a survey of heart rate in heart failure in Sweden (HR-HF study). Clin Res Cardiol https://doi.org/10.1007/s00392-017-1146-6 (pMID: 28795299, [Epub ahead of print])

    Article  PubMed  PubMed Central  Google Scholar 

  9. Fröhlich H, Torres L, Täger T, Schellberg D, Corletto A, Kazmi S, Goode K, Grundtvig M, Hole T, Katus HA, Cleland JGF, Atar D, Clark AL, Agewall S, Frankenstein L (2017) Bisoprolol compared with carvedilol and metoprolol succinate in the treatment of patients with chronic heart failure. Clin Res Cardiol https://doi.org/10.1007/s00392-017-1115-0 (pMID: 28434020, [Epub ahead of print])

    Article  PubMed  Google Scholar 

  10. Yancy CW, Jessup M, Bozkurt B et al (2016) ACC/AHA/HFSA focused update on new pharmacological therapy for heart failure: an update of the 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. J Am Coll Cardiol 68:1476–1488

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cardiology, Heraklion University Hospital, Voutes, 7100, Heraklion-Crete, Greece

    Eleni S. Nakou, Maria E. Marketou, Panos E. Vardas & Fragiskos I. Parthenakis

Authors
  1. Eleni S. Nakou
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Maria E. Marketou
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Panos E. Vardas
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Fragiskos I. Parthenakis
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Eleni S. Nakou.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nakou, E.S., Marketou, M.E., Vardas, P.E. et al. The clinical relevance of drug–drug interaction between co-trimoxazole and sacubitril/valsartan treatment in a heart failure patient: a case report and overview of mechanisms and management in clinical practice. Clin Res Cardiol 107, 524–526 (2018). https://doi.org/10.1007/s00392-018-1201-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00392-018-1201-y

Search

Navigation